DMIC
GILD icon

Dixon Mitchell Investment Counsel’s Gilead Sciences GILD Stock Holding History

Dixon Mitchell Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76
Closed -$7.02K – 111
2024
Q4 		$7.02K Buy
+76
New +$6.84K ﹤0.01% 96

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Dixon Mitchell Investment Counsel's GILD Position: Q1 2025 in Review

Dixon Mitchell Investment Counsel sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 76 shares — an estimated $7.02K sold.

Dixon Mitchell Investment Counsel first reported a position in GILD in Q4 2024 and held it in 1 quarter. The position peaked at $7.02K in Q4 2024. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Dixon Mitchell Investment Counsel reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Dixon Mitchell Investment Counsel sold 76 Gilead Sciences shares in Q1 2025, an estimated $7.02K.
  • Dixon Mitchell Investment Counsel first reported a position in Gilead Sciences in Q4 2024 and held it in 1 quarter.
  • Dixon Mitchell Investment Counsel's Gilead Sciences position peaked at $7.02K in Q4 2024.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q1 2025, filed 14 May 2025.